After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Pinpointing who will and won’t get Alzheimer’s disease is tricky for doctors, but new research suggests it may soon get ...

INmune Bio said on Monday its experimental Alzheimer's drug failed to improve cognitive functions in patients with early ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

An autopsy study of a 45-year-old former U.S. Navy crewman with severe chronic traumatic encephalopathy (CTE) suggested that ...

Maria Shriver helped launch a Las Vegas clinic to uncover why Alzheimer’s affects women most — and how lifestyle changes may ...

Tulane University researchers created a first-of-its-kind subcellular map of an area of the brain commonly affected by ...

Among members of the Richardson family who carry a mutation in the PSEN1 gene, the average age when symptoms start is 39.

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Smaller, shallow brain folds in the posteromedial cortex show greater thinning with age and Alzheimer’s disease, and their ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...